Clinical Trials Browser

Phase 1/2 × Myelodysplastic Syndromes × Infusions, Intravenous × Clear all

NCT05448599 2023-03-15

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute